查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600609

臨床試驗設備和輔助解決方案市場：按產品類型、階段、最終用途和適應症分類 - 2025-2030 年全球預測

Clinical Trial Equipment & Ancillary Solutions Market by Product (Equipment, Services, Systems), Type (Biologic Drugs, Medical Devices, Small Molecules), Phase, End-Use, Indication - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年臨床試驗設備及輔助解決方案市場規模為42.1億美元，預計2024年將達到45.8億美元，複合年成長率為8.81%，2030年將達到76.2億美元。

臨床試驗設備和輔助解決方案市場包括各種基本產品和服務，可確保合規性、效率、準確性並促進臨床試驗的進行。這包括醫療設備、監控設備、實驗室用品以及資料管理軟體和病患監測系統等 IT 解決方案。對這些解決方案的需求是由簡化臨床試驗業務、提高資料完整性和增強病患安全的關鍵需求所驅動的。其應用涵蓋臨床試驗的各個階段，從患者招募和監測到資料收集和監管合規性。最終用戶主要是製藥公司、生技公司和代表申辦者進行臨床試驗的 CRO（委外研發機構）。

主要市場統計
基準年[2023] 42.1億美元
預測年份 [2024] 45.8億美元
預測年份 [2030] 76.2億美元
複合年成長率（%） 8.81%

該市場的關鍵成長要素包括由於研發投資增加而導致的臨床試驗量增加、臨床試驗的複雜性增加以及需要先進設備和解決方案的嚴格監管要求。此外，臨床試驗設備中的人工智慧和物聯網整合等技術進步透過實現遠端監控和增強即時資料分析提供了龐大的商機。由於成本優勢和多樣化的人群，臨床試驗活動不斷擴大，新興市場存在重大機會。建立本地夥伴關係和投資在地化技術解決方案是利用這些機會的建議策略。

然而，新興市場面臨高成本和與先進設備相關的基礎設施不足等挑戰，這可能會抑製成長。不斷變化的法規以及頻繁更新和檢驗設備的需要也是主要障礙。行動醫療技術、分散式測試和模組化測試解決方案的創新和研究是業務成長的有希望的領域，有可能克服現有的限制並回應不斷變化的市場需求。總體而言，市場的特點是技術快速發展以及對臨床試驗準確性和效率的要求不斷提高，公司需要具有適應性和前瞻性思維，以有效捕捉其成長潛力，並保持自己的方法極為重要。

市場動態：快速發展的臨床試驗設備和輔助解決方案市場的關鍵市場洞察

供需的動態交互作用正在改變臨床試驗設備和輔助解決方案市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 確定新藥和醫療設備安全有效使用的需要
    • 全球臨床試驗活動外包
    • 增加臨床試驗設備和輔助解決方案研發活動的投資
  • 市場限制因素
    • 與雲端基礎的臨床試驗解決方案相關的資料安全風險
  • 市場機會
    • 政府對藥物開發和臨床試驗的措施和支持
    • 將人工智慧 (AI) 和資料分析整合到臨床試驗解決方案中
  • 市場挑戰
    • 臨床試驗跨境物流程序的複雜性

波特的五力：駕馭臨床試驗設備和輔助解決方案市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對臨床試驗設備和輔助解決方案市場的影響

外部宏觀環境因素在塑造臨床試驗設備和輔助解決方案市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解臨床試驗設備和輔助解決方案市場的競爭格局

臨床試驗設備和輔助解決方案市場的詳細市場佔有率分析提供了對供應商績效的全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣臨床試驗設備及輔助解決方案市場供應商績效評估

FPNV 定位矩陣是評估臨床試驗設備和輔助解決方案市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析：

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 需要確定如何安全有效地使用新藥品和醫療設備
      • 外包世界各地的臨床試驗活動
      • 增加臨床試驗設備和輔助解決方案研發活動的投資
    • 抑制因素
      • 與雲端基礎的臨床試驗解決方案相關的資料安全風險
    • 機會
      • 政府對藥物開發和臨床試驗的措施和支持
      • 將人工智慧 (AI) 和資料分析整合到臨床試驗解決方案中
    • 任務
      • 臨床試驗跨境物流流程的複雜性
  • 市場區隔分析
    • 產品：在設備租賃和租賃服務中增加使用輔助採購服務
    • 類型：臨床檢測設備在生物藥生產過程中的應用日益增多
    • 適應症：對分析胃腸道疾病的臨床試驗設備的需求不斷成長
    • 階段：II期增加使用臨床試驗設備和輔助解決方案來評估藥物療效
    • 最終用途：擴大臨床試驗設備在生技和製藥公司的應用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章臨床試驗設備與輔助解決方案市場：依產品

  • 裝置
    • 診斷影像設備
    • 實驗設備
  • 服務
    • 輔助採購服務
      • 設備租賃及出租服務
      • 採購
      • 供應和物流
    • 資料管理和分析服務
    • 維護和校準服務
    • 監理和合規服務
    • 現場監控與支援服務
    • 培訓和諮詢服務
  • 系統
    • 臨床試驗管理系統
    • 電子資料擷取系統
    • 隨機化和臨床實驗供應管理

第7章臨床試驗設備和輔助解決方案市場：按類型

  • 生物製藥
  • 醫療設備
  • 小分子

第8章臨床試驗設備及輔助解決方案市場分階段狀況

  • 第一階段
  • 第二階段
  • 第三階段
  • 第四階段

第9章臨床試驗設備與輔助解決方案市場：依最終用途分類

  • 學術研究所
  • 生物技術和製藥公司
  • 合約調查機構
  • 醫療設備公司

第10章臨床試驗設備與輔助解決方案市場（按適應症）

  • 血液疾病
  • 心血管疾病
  • 中樞神經系統和精神障礙
  • 消化系統疾病
  • 免疫學
  • 感染疾病
  • 代謝紊亂
  • 腫瘤學

第11章美洲臨床試驗設備及輔助解決方案市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太臨床試驗設備及輔助解決方案市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲臨床試驗設備及輔助解決方案市場

  • 丹麥
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • RQM+ 收購 Libra Medical
    • Lambda Therapeutics 與 Medidata 合作，實現資料管理流程自動化和簡化，並提高臨床試驗效率。
    • Mednet 在 iMednet eClinical 平台中推出 DICOM 成像功能
    • Launch Therapeutics 選擇 Medidata AI 智慧試驗加速臨床試驗開發
    • Clinical ink 宣布與 Mural Health 建立策略合作夥伴關係，以提供新患者支付和物流能力
    • Cloudbyz 推出突破性電子資料擷取解決方案，以簡化臨床研究並加速新治療方法的推出
    • Clario 發布用於臨床試驗的雲端基礎的影像檢視器
    • ClinChoice 透過收購 CRO 繼續擴張
    • Suvoda推出專用軟體平台
    • Huma 收購 Arcedis 擴大臨床試驗平台
    • CardieX 子公司 ATCOR 與 Invariant 合作，利用先進的人工智慧醫療技術進行臨床試驗
    • RQM+推出臨床試驗服務
    • Edison Partners主導臨床試驗資訊中斷公司 Locavant 的 2,100 萬美元資金籌措
    • PAREXEL 在中國蘇州開設臨床試驗用品和物流倉庫
    • 飛利浦推出用於分散臨床試驗的 12 導程心電圖解決方案

公司名單

  • Eurofins Scientific SE
  • Veeva Systems Inc.
  • Yokogawa Electric Corporation
  • United Parcel Service, Inc.
  • Thermo Fisher Scientific, Inc.
  • Quipment SAS
  • Emsere BV
  • Dassault Systemes SE
  • Parexel International Corporation
  • Lonza Group Ltd.
  • Global Vision Technologies, Inc.
  • Oracle Corporation
  • Charles River Laboratories International, Inc.
  • Axelerist
  • Zifo Technologies Private Limited
  • B. Braun SE
  • Bio-Rad Laboratories, Inc.
  • Eppendorf SE
  • IQVIA Holdings Inc.
  • Almac Group Limited
  • Navitas Inc.
  • Quanticate International Limited
  • Ancillare, LP
  • Royal Philips
  • MedNet Solutions, Inc.
  • Avantor, Inc.
  • Myonex, Inc.
  • Hitachi, Ltd.
Product Code: MRR-8C74ADFC1246

The Clinical Trial Equipment & Ancillary Solutions Market was valued at USD 4.21 billion in 2023, expected to reach USD 4.58 billion in 2024, and is projected to grow at a CAGR of 8.81%, to USD 7.62 billion by 2030.

The Clinical Trial Equipment & Ancillary Solutions market encompasses a variety of essential products and services that facilitate the execution of clinical studies, ensuring compliance, efficiency, and accuracy. This includes medical devices, monitoring equipment, lab supplies, and IT solutions such as software for data management and patient monitoring systems. The necessity of these solutions is driven by the critical need to streamline trial operations, improve data integrity, and enhance patient safety. Their application spans various phases of clinical trials, from patient recruitment and monitoring to data collection and regulatory compliance. End-use primarily involves pharmaceutical and biotechnology companies, along with Contract Research Organizations (CROs) that conduct clinical trials on behalf of sponsors.

KEY MARKET STATISTICS
Base Year [2023] USD 4.21 billion
Estimated Year [2024] USD 4.58 billion
Forecast Year [2030] USD 7.62 billion
CAGR (%) 8.81%

Key growth influencers in this market include the rise in clinical trial volume driven by increasing investments in R&D, the growing complexity of trials, and stringent regulatory requirements demanding advanced equipment and solutions. Additionally, technological advancements such as the integration of AI and IoT in clinical trial equipment present substantial opportunities, enabling remote monitoring and enhancing real-time data analysis. A prominent opportunity lies in emerging markets where clinical trial activity is expanding due to cost advantages and diverse populations. Establishing local partnerships and investing in localized technology solutions are recommended strategies to capitalize on these opportunities.

However, the market faces challenges such as high costs associated with advanced equipment and inadequate infrastructure in developing regions, which might impede growth. Regulatory changes and the need for frequent updates and validation of equipment also pose significant hurdles. Innovation and research in mobile health technologies, decentralized trials, and modular trial solutions are promising areas for business growth, offering potential to overcome existing limitations and cater to evolving market needs. Overall, the market is characterized by rapid technological evolution and increasing demand for precision and efficiency in clinical trials, making it crucial for businesses to stay adaptive and forward-thinking in their approach to capture the growth potential effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Clinical Trial Equipment & Ancillary Solutions Market

The Clinical Trial Equipment & Ancillary Solutions Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Need to determine the safe and effective use of new drugs and medical device
    • Outsourcing of clinical trial activity across the globe
    • Increasing investment in R&D activities for clinical trials equipment & ancillary solutions
  • Market Restraints
    • Data security risks associated with cloud-based clinical trial solutions
  • Market Opportunities
    • Government initiatives and support for drug development and clinical trials
    • Integration of artificial intelligence (AI) and data analytics in clinical trial solutions
  • Market Challenges
    • Complexities in procedures of cross border logistics for clinical trials

Porter's Five Forces: A Strategic Tool for Navigating the Clinical Trial Equipment & Ancillary Solutions Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Clinical Trial Equipment & Ancillary Solutions Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Clinical Trial Equipment & Ancillary Solutions Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Clinical Trial Equipment & Ancillary Solutions Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Clinical Trial Equipment & Ancillary Solutions Market

A detailed market share analysis in the Clinical Trial Equipment & Ancillary Solutions Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Clinical Trial Equipment & Ancillary Solutions Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Clinical Trial Equipment & Ancillary Solutions Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Equipment & Ancillary Solutions Market, highlighting leading vendors and their innovative profiles. These include Eurofins Scientific SE, Veeva Systems Inc., Yokogawa Electric Corporation, United Parcel Service, Inc., Thermo Fisher Scientific, Inc., Quipment SAS, Emsere B.V., Dassault Systemes SE, Parexel International Corporation, Lonza Group Ltd., Global Vision Technologies, Inc., Oracle Corporation, Charles River Laboratories International, Inc., Axelerist, Zifo Technologies Private Limited, B. Braun SE, Bio-Rad Laboratories, Inc., Eppendorf SE, IQVIA Holdings Inc., Almac Group Limited, Navitas Inc., Quanticate International Limited, Ancillare, LP, Royal Philips, MedNet Solutions, Inc., Avantor, Inc., Myonex, Inc., and Hitachi, Ltd..

Market Segmentation & Coverage

This research report categorizes the Clinical Trial Equipment & Ancillary Solutions Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Equipment, Services, and Systems. The Equipment is further studied across Imaging & Diagnostic Equipment and Laboratory Equipment. The Services is further studied across Ancillary Sourcing Services, Data Management & Analysis Services, Maintenance & Calibration Services, Regulatory & Compliance Services, Site Monitoring & Support Services, and Training & Consulting Services. The Ancillary Sourcing Services is further studied across Equipment Leasing & Rental Services, Procurement, and Supply & Logistics. The Systems is further studied across Clinical Trial Management Systems, Electronic Data Capture Systems, and Randomization & Trial Supply Management.
  • Based on Type, market is studied across Biologic Drugs, Medical Devices, and Small Molecules.
  • Based on Phase, market is studied across Phase I, Phase II, Phase III, and Phase IV.
  • Based on End-Use, market is studied across Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, Contract Research Organizations, and Medical Device Companies.
  • Based on Indication, market is studied across Blood Disorders, Cardiovascular Diseases, CNS & Mental Disorders, Digestive Disorders, Immunology, Infectious Diseases, Metabolic Disorders, and Oncology.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Finland, France, Germany, Israel, Italy, Netherlands, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need to determine the safe and effective use of new drugs and medical device
      • 5.1.1.2. Outsourcing of clinical trial activity across the globe
      • 5.1.1.3. Increasing investment in R&D activities for clinical trials equipment & ancillary solutions
    • 5.1.2. Restraints
      • 5.1.2.1. Data security risks associated with cloud-based clinical trial solutions
    • 5.1.3. Opportunities
      • 5.1.3.1. Government initiatives and support for drug development and clinical trials
      • 5.1.3.2. Integration of artificial intelligence (AI) and data analytics in clinical trial solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Complexities in procedures of cross border logistics for clinical trials
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing utilization of ancillary sourcing services for equipment leasing & rental services
    • 5.2.2. Type: Increasing application of clinical trial equipment in the manufacturing process of biological drugs
    • 5.2.3. Indication: Rising preferences for clinical trial equipment to analyze digestive disorders
    • 5.2.4. Phase: Growing usage of clinical trial equipments & ancillary solutions in phase II to assess effectiveness of drug
    • 5.2.5. End-Use: Expanding application of clinical trial equipment in biotechnology & pharmaceutical companies
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Clinical Trial Equipment & Ancillary Solutions Market, by Product

  • 6.1. Introduction
  • 6.2. Equipment
    • 6.2.1. Imaging & Diagnostic Equipment
    • 6.2.2. Laboratory Equipment
  • 6.3. Services
    • 6.3.1. Ancillary Sourcing Services
      • 6.3.1.1. Equipment Leasing & Rental Services
      • 6.3.1.2. Procurement
      • 6.3.1.3. Supply & Logistics
    • 6.3.2. Data Management & Analysis Services
    • 6.3.3. Maintenance & Calibration Services
    • 6.3.4. Regulatory & Compliance Services
    • 6.3.5. Site Monitoring & Support Services
    • 6.3.6. Training & Consulting Services
  • 6.4. Systems
    • 6.4.1. Clinical Trial Management Systems
    • 6.4.2. Electronic Data Capture Systems
    • 6.4.3. Randomization & Trial Supply Management

7. Clinical Trial Equipment & Ancillary Solutions Market, by Type

  • 7.1. Introduction
  • 7.2. Biologic Drugs
  • 7.3. Medical Devices
  • 7.4. Small Molecules

8. Clinical Trial Equipment & Ancillary Solutions Market, by Phase

  • 8.1. Introduction
  • 8.2. Phase I
  • 8.3. Phase II
  • 8.4. Phase III
  • 8.5. Phase IV

9. Clinical Trial Equipment & Ancillary Solutions Market, by End-Use

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Biotechnology & Pharmaceutical Companies
  • 9.4. Contract Research Organizations
  • 9.5. Medical Device Companies

10. Clinical Trial Equipment & Ancillary Solutions Market, by Indication

  • 10.1. Introduction
  • 10.2. Blood Disorders
  • 10.3. Cardiovascular Diseases
  • 10.4. CNS & Mental Disorders
  • 10.5. Digestive Disorders
  • 10.6. Immunology
  • 10.7. Infectious Diseases
  • 10.8. Metabolic Disorders
  • 10.9. Oncology

11. Americas Clinical Trial Equipment & Ancillary Solutions Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Clinical Trial Equipment & Ancillary Solutions Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Finland
  • 13.4. France
  • 13.5. Germany
  • 13.6. Israel
  • 13.7. Italy
  • 13.8. Netherlands
  • 13.9. Norway
  • 13.10. Poland
  • 13.11. Qatar
  • 13.12. Russia
  • 13.13. Saudi Arabia
  • 13.14. South Africa
  • 13.15. Spain
  • 13.16. Sweden
  • 13.17. Switzerland
  • 13.18. United Arab Emirates
  • 13.19. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. RQM+ Acquires Libra Medical
    • 14.3.2. Lambda Therapeutics partners with Medidata to automate and streamline data management processes for greater clinical trial efficiency
    • 14.3.3. Mednet Launches DICOM Imaging Capabilities Within the iMednet eClinical Platform
    • 14.3.4. Launch Therapeutics Selects Medidata AI Intelligent Trials to Accelerate Clinical Trial Development
    • 14.3.5. Clinical ink Announces Strategic Partnership with Mural Health for New Patient Payment and Logistics Capabilities
    • 14.3.6. Cloudbyz Unveils Groundbreaking Electronic Data Capture Solution to Streamline Clinical Research and Accelerate Launch of New Therapies
    • 14.3.7. Clario Launches Cloud-Based Image Viewer for Clinical Trials
    • 14.3.8. ClinChoice continues expansion with CRO acquisition
    • 14.3.9. Suvoda launches purpose-built software platform
    • 14.3.10. Huma acquires Alcedis to expand clinical trial platform
    • 14.3.11. CardieX Subsidiary ATCOR Partners with Invaryant to Enable Clinical Trials with Advanced New AI Medical Technology
    • 14.3.12. RQM+ Launches Clinical Trial Services
    • 14.3.13. Edison Partners leads USD 21 million funding round for clinical trial intelligence disruptor Lokavant
    • 14.3.14. Parexel Opens Clinical Trial Supplies and Logistics Depot in Suzhou, China
    • 14.3.15. Philips launches 12-lead ECG solution for decentralized clinical trials

Companies Mentioned

  • 1. Eurofins Scientific SE
  • 2. Veeva Systems Inc.
  • 3. Yokogawa Electric Corporation
  • 4. United Parcel Service, Inc.
  • 5. Thermo Fisher Scientific, Inc.
  • 6. Quipment SAS
  • 7. Emsere B.V.
  • 8. Dassault Systemes SE
  • 9. Parexel International Corporation
  • 10. Lonza Group Ltd.
  • 11. Global Vision Technologies, Inc.
  • 12. Oracle Corporation
  • 13. Charles River Laboratories International, Inc.
  • 14. Axelerist
  • 15. Zifo Technologies Private Limited
  • 16. B. Braun SE
  • 17. Bio-Rad Laboratories, Inc.
  • 18. Eppendorf SE
  • 19. IQVIA Holdings Inc.
  • 20. Almac Group Limited
  • 21. Navitas Inc.
  • 22. Quanticate International Limited
  • 23. Ancillare, LP
  • 24. Royal Philips
  • 25. MedNet Solutions, Inc.
  • 26. Avantor, Inc.
  • 27. Myonex, Inc.
  • 28. Hitachi, Ltd.

LIST OF FIGURES

  • FIGURE 1. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET RESEARCH PROCESS
  • FIGURE 2. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET DYNAMICS
  • TABLE 7. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY IMAGING & DIAGNOSTIC EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY LABORATORY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT LEASING & RENTAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PROCUREMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SUPPLY & LOGISTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY DATA MANAGEMENT & ANALYSIS SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MAINTENANCE & CALIBRATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY REGULATORY & COMPLIANCE SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SITE MONITORING & SUPPORT SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TRAINING & CONSULTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ELECTRONIC DATA CAPTURE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY RANDOMIZATION & TRIAL SUPPLY MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CNS & MENTAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 76. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 78. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 83. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 84. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 85. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 87. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 92. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 93. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 94. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 96. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 97. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 106. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 118. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 120. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 122. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 126. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 127. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 129. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 130. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 131. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 132. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 134. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 135. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 136. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 138. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 139. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 140. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 141. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 143. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 144. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 145. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 147. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 148. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 149. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 150. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 152. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 153. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 154. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 156. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 157. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 158. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 159. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 161. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 162. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 163. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 165. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 166. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 167. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 168. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 170. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 171. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 172. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 174. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 175. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 176. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 177. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 179. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 180. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 181. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 183. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 184. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 185. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 186. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 188. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 189. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 190. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 192. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 193. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 194. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 195. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 199. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 200. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 201. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 202. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 203. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 204. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 206. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 207. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 208. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 209. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 210. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 211. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 212. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 213. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 215. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 216. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 217. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 219. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 220. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 221. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 222. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 224. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 225. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 236. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 237. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 238. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 239. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 240. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 241. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 243. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 244. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 245. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 246. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 247. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 248. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 249. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 250. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 252. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 253. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 254. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 255. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 256. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 257. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 258. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 259. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 261. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 262. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 263. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 264. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 265. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 266. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 267. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 268. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 270. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 271. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 272. ISRAEL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS